CD8A and hepatocellular carcinoma: We did not find any phenotypical differences of antigen-experienced MAGE-A-specific CD8+ T cells present in these HCC patients with verified antigen expression compared to the overall tested cohort of HCC patients in which we could not confirm respective TAA expression due to the lack of appropriate tumor samples (Supplementary Figure 3C–3G).